These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Analysis of proliferating biliary epithelial cells in human liver disease using a monoclonal antibody against DNA polymerase alpha. Seki S, Sakaguchi H, Kawakita N, Yanai A, Kuroki T, Kobayashi K. Virchows Arch A Pathol Anat Histopathol; 1993; 422(2):133-43. PubMed ID: 7682020 [Abstract] [Full Text] [Related]
4. Immunohistochemical study on phenotypical changes of hepatocytes in liver disease with reference to extracellular matrix composition. Matsumoto S, Yamamoto K, Nagano T, Okamoto R, Ibuki N, Tagashira M, Tsuji T. Liver; 1999 Feb; 19(1):32-8. PubMed ID: 9928763 [Abstract] [Full Text] [Related]
5. Biliary expression of heat shock protein: a non-specific feature of chronic cholestatic liver diseases. Martins EB, Chapman RW, Marron K, Fleming KA. J Clin Pathol; 1996 Jan; 49(1):53-6. PubMed ID: 8666687 [Abstract] [Full Text] [Related]
6. [Protein-copper complex in primary biliary cirrhosis and other chronic diffuse diseases of the liver]. Loginov AS, Aruin LI, Shepeleva SD. Arkh Patol; 1980 Jan; 42(4):50-5. PubMed ID: 7396755 [Abstract] [Full Text] [Related]
8. In situ distribution of enolase isozymes in chronic liver disease. Fukuda Y, Miyazawa Y, Imoto M, Koyama Y, Nakano I, Nagura H, Kato K. Am J Gastroenterol; 1989 Jun; 84(6):601-5. PubMed ID: 2729230 [Abstract] [Full Text] [Related]
9. Increased MUC6 apomucin expression is a characteristic of reactive biliary epithelium in chronic viral hepatitis. Sasaki M, Nakanuma Y, Ho SB, Kim YS. J Pathol; 1998 Jun; 185(2):191-8. PubMed ID: 9713347 [Abstract] [Full Text] [Related]
12. Hepatic expression of type A and type B receptors for tumor necrosis factor. Volpes R, van den Oord JJ, De Vos R, Desmet VJ. J Hepatol; 1992 Mar; 14(2-3):361-9. PubMed ID: 1323602 [Abstract] [Full Text] [Related]
13. Expression of uncoupling protein-2 in biliary epithelial cells in primary biliary cirrhosis. Taniguchi E, Harada M, Kawaguchi T, Koga H, Kumemura H, Hanada S, Shishido S, Baba S, Kumashiro R, Ueno T, Sakisaka S, Sata M. Liver; 2002 Dec; 22(6):451-8. PubMed ID: 12445169 [Abstract] [Full Text] [Related]
14. In situ detection of oxidative DNA damage, 8-hydroxydeoxyguanosine, in chronic human liver disease. Kitada T, Seki S, Iwai S, Yamada T, Sakaguchi H, Wakasa K. J Hepatol; 2001 Nov; 35(5):613-8. PubMed ID: 11690707 [Abstract] [Full Text] [Related]
16. The common pattern of cytokeratin alteration in alcoholic and cholestatic liver disease is different from that of hepatitic liver damage. A study with the panepithelial monoclonal antibody lu-5. Müllhaupt B, Gudat F, Epper R, Bianchi L. J Hepatol; 1993 Aug; 19(1):23-35. PubMed ID: 7507954 [Abstract] [Full Text] [Related]
18. Frequent expression of MUC1 apomucin on biliary epithelial cells of damaged small bile ducts in primary biliary cirrhosis and chronic viral hepatitis: an immunohistochemical study. Sasaki M, Nakanuma Y. Hepatology; 1996 Jun; 23(6):1313-7. PubMed ID: 8675144 [Abstract] [Full Text] [Related]